PTC Therapeutics Inc. has continued its string of Big Pharma tie-ups with its latest deal with Roche. The two companies announced Nov. 28 that they have entered into another venture, the first between the Big Pharma and the biotech since their deal in 2009. Roche is just one of PTC’s large pharmaceutical partners, which also include Merck & Co. Inc. and AstraZeneca PLC.
Roche Inks A Second Deal With PTC Therapeutics, Pays $30M Upfront
The Big Pharma teams up with a biotech and a patient advocacy foundation to develop treatments for a rare genetic disorder.